Search results
Google’s $6 A Month Chrome Security Subscription Is A Thing Now
Forbes· 6 days agoGoogle's Chrome browser is used by an estimated 65% of the world's internet-using population, which...
Palo Alto Networks Raises the Bar Delivering the Most Comprehensive SASE Capabilities
KTLA-TV Los Angeles· 4 hours agoPalo Alto Networks (NASDAQ: PANW), the global cybersecurity leader, announced its latest innovations to future-proof and transform the workforce with the launch of Prisma® SASE 3.0. Prisma SASE ...
The Top 3 Cybersecurity Stocks to Buy in April 2024
InvestorPlace· 5 days ago2023 was a record year for ransomware attacks, with companies like MGM Resorts International (NYSE:MGM) suffering largely publicized attacks. The only defense will be more investments in cybersecurity ...
Microsoft CEO says it is "putting security above all else" in major refocus
TechRadar via Yahoo News· 6 days agoNadella highlighted ongoing efforts to enhance protection while also bolstering threat monitoring...
Arista targets lateral security threat in campus and data center networks
Network World· 1 day agoArista Networks is bolstering a key part of its security software with new features that help...
Security updates from Google Cloud Next '24 center on GenAI | TechTarget
SearchSecurity.com· 2 days agoA few weeks ago at Google Cloud Next '24, we saw progress on Google's generative AI vision with updates that apply GenAI across several security offerings to help solve pressing ...
Q1 2024 Merit Medical Systems Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 1 day agoWe completed collection of safety and efficacy outcomes throughout this study follow-up period and receive primary endpoint data for the last enrolled patient during the first ...
3 best enterprise mobile app authentication methods | TechTarget
SearchSecurity.com· 1 day agoWhen developing a mobile app, choose an authentication method that balances security and user experience. Dev teams should look into the different types of authentication ...
Veru to Report Fiscal 2024 Second Quarter Financial Results on May 8, 2024
Morningstar· 1 day agoVeru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for preserving muscle for high quality weight loss, oncology, and viral induced ...
Veru to Present at the GLP-1 Based Therapeutics Summit
Morningstar· 4 hours ago...controlled, randomized, dose-finding clinical trial was designed to evaluate the safety and efficacy of enobosarm 3mg, enobosarm 6mg, or placebo as a treatment to preserve muscle and augment fat loss in approximately 90 patients with sarcopenic obesity or overweight elderly (>60 years of age)...